Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects

1. OBJECTIVES: Parkinson's disease (PD) afflicts approximately 1-2% of the population over 50 years of age. No cures or effective modifying treatments exist and clinical diagnosis is currently confounded by a lack of definitive biomarkers. We sought to discover potential biomarkers in the cereb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maarouf, Chera L., Beach, Thomas G., Adler, Charles H., Shill, Holly A., Sabbagh, Marwan N., Wu, Terence, Walker, Douglas G., Kokjohn, Tyler A., Roher, Alex E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3681206/
https://ncbi.nlm.nih.gov/pubmed/22889670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1179/1743132812Y.0000000063
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares